Snehasikta Swarnakar

Title: Innovations of Snehasikta Swarnakar in Anti-Inflammatory Research.

Introduction

Snehasikta Swarnakar is a notable inventor based in West Bengal, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as anti-inflammatory agents. His work focuses on addressing critical health issues such as gastric ulcers and other inflammatory diseases.

Latest Patents

Snehasikta Swarnakar holds a patent for "3-indolyl furanoids as inhibitors of matrix metalloproteinase-9 for prevention of gastric ulcer and other inflammatory diseases." This patent discloses 3-indolyl furanoid compounds that are effective in inhibiting matrix metalloproteinase-9 (MMP-9) expression in the gastric mucosal layer. The compounds are designed to be potent anti-inflammatory agents, with a noted IC50 value of 50 µM for one of the 3-indolyl furanoids. The patent outlines various embodiments related to the preparation and use of these compounds in treating diseases associated with gastric ulcers and other inflammatory conditions.

Career Highlights

Snehasikta Swarnakar is affiliated with the Council of Scientific and Industrial Research, where he conducts research aimed at developing innovative solutions for health-related challenges. His work has garnered attention for its potential impact on the treatment of inflammatory diseases.

Collaborations

Snehasikta has collaborated with notable colleagues such as Parasuraman Jaisankar and Sourav Chatterjee. These collaborations have contributed to the advancement of research in the field of medicinal chemistry.

Conclusion

Snehasikta Swarnakar's innovative work in developing anti-inflammatory compounds highlights his commitment to addressing significant health issues. His contributions to the field are paving the way for new treatments for gastric ulcers and other inflammatory diseases.